Healthcare Services Group (HCSG) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Dec, 2025Executive summary
Q1 2025 revenue grew 5.7% year-over-year to $447.7 million, marking the best quarterly revenue and cash flow in five years, driven by new client wins and strong collections in both Housekeeping and Dietary segments.
Net income increased 12.5% to $17.2 million, with diluted EPS of $0.23, up from $0.21 in Q1 2024.
Cash flow from operations, excluding payroll accrual changes, was $32.1 million, up $41.3 million year-over-year.
Strategic priorities for 2025 include management development, sales pipeline conversion, cost management, and cash flow optimization.
Housekeeping contributed 43.9% and Dietary 56.1% of total revenues, serving approximately 2,800 facilities nationwide.
Financial highlights
Cost of services was $379.7 million (84.8% of revenue); SG&A was $45.0 million, or $46.4 million (10.4%) after adjustments.
EBITDA for Q1 2025 was $26.9 million; adjusted EBITDA was $30.6 million, 6.8% of revenue.
Cash and marketable securities totaled $143.9 million at quarter-end; $500 million credit facility available and undrawn.
Repurchased $7 million in common stock during Q1; $23 million repurchased since February 2023 authorization, with 5.4 million shares remaining under authorization.
Received $12.2 million in CARES Act/Employee Retention Credit refunds, recorded as a deferred liability.
Outlook and guidance
Q2 revenue expected between $445 million and $455 million; second half revenue projected to grow sequentially.
2025 cash flow from operations guidance (excluding payroll accrual changes) raised to $60–$75 million.
SG&A expected in the 9.5–10.5% range near term, with a long-term goal of 8.5–9.5%.
Cost of services targeted to be managed in the 86% range for 2025.
Annual revenue growth expected in the mid-single digits.
Latest events from Healthcare Services Group
- Revenue up 7.1% to $1.84B, net income $59.1M, $75M buyback, 2026 growth outlook strong.HCSG
Q4 202511 Feb 2026 - Q2 revenue rose 1.8% to $426.3M, but a large bad debt charge drove a net loss of $1.8M.HCSG
Q2 20243 Feb 2026 - Q3 2024 revenue and net income grew, with strong cash flow and reaffirmed guidance.HCSG
Q3 202419 Jan 2026 - Q4 revenue grew to $437.8M, but net income and margins fell; 2025 growth expected.HCSG
Q4 202423 Dec 2025 - 2024 saw growth, high retention, and strong governance, with key votes on directors, pay, and audit.HCSG
Proxy Filing1 Dec 2025 - Q2 revenue up 7.6%, $61.2M charge drives $32.4M loss, $50M buyback and higher cash flow planned.HCSG
Q2 202516 Nov 2025 - Q3 revenue up 8.5% to $464.3M, net income $43M, aided by ERC refunds and strong segment growth.HCSG
Q3 202524 Oct 2025